Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity

被引:12
|
作者
Forster, A. J. [1 ,2 ]
Daneman, N. [2 ,3 ]
van Walraven, C. [1 ,2 ]
机构
[1] Univ Ottawa, Ottawa Hosp, Dept Med, Res Inst, Ottawa, ON, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON, Canada
[3] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto Hosp, Toronto, ON, Canada
关键词
Hospital-acquired infection; Clostridium difficile infection; Antibiotics; Competing risks; Time-dependent covariates; Proportional hazards modelling; RISK; TIME; INPATIENT;
D O I
10.1016/j.jhin.2016.10.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Previous studies of the association between antibiotic exposure and risk of hospital-acquired Clostridium difficile-associated infection (CDI) have not fully accounted for patient severity of illness, and competing risks. Aim: To determine the potential effects of interventions on hospital-acquired CDI risk. Methods: All adults admitted to a teaching hospital between 2004 and 2014 for more than two days were included. Exposures to all antibiotics and cases of CDI were determined. Patients were followed until discharge from hospital, death, or acquisition of hospitalacquired CDI (defined as positive toxin assay in unformed stool > 2 days following admission). Multivariable proportional hazards competing-risks modelling with time-dependent covariates was used, accounting for patient severity of illness using the Escobar model. Findings: In all, 208,104 patients were studied. Hospital-acquired CDI risk was 0.46 events per 1000 patient-days, decreasing significantly during the study period. Compared to the 5(th) percentile hospital death risk (0.02%), patients with a 50% risk of death in hospital had an adjusted hazard ratio (aHR) of hospital-acquired CDI of 5.5. Exposure to some antibiotics significantly increased hospital-acquired CDI risk, being highest for carbapenems (aHR: 1.47 after one week of continuous exposure) and intravenous vancomycin (aHR: 1.53). On the ward, sharing a room with other patients newly diagnosed with CDI significantly increased the risk of subsequent disease (aHR: 1.16 on CDI diagnosis day). Conclusion: The primary determinant of hospital-acquired CDI was patient severity of illness. Exposure to both antibiotics and other patients with CDI significantly increased the subsequent risk of hospital-acquired CDI but this risk was small relative to patient severity of illness. (C) 2016 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:400 / 409
页数:10
相关论文
共 50 条
  • [31] Clinical Performance Evaluation of a Machine Learning System for Predicting Hospital-Acquired Clostridium Difficile Infection
    Teeple, Erin
    Hartvigsen, Thomas
    Sen, Cansu
    Claypool, Kajal
    Rundensteiner, Elke
    PROCEEDINGS OF THE 13TH INTERNATIONAL JOINT CONFERENCE ON BIOMEDICAL ENGINEERING SYSTEMS AND TECHNOLOGIES, VOL 5: HEALTHINF, 2020, : 656 - 663
  • [32] Temporal Changes in Serum Albumin and Total Protein in Patients with Hospital-acquired Clostridium difficile Infection
    Kumarappa, V. Sumana
    Patel, Hiren
    Shah, Anish
    Baddoura, Walid
    DeBari, Vincent A.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2014, 44 (01): : 32 - 37
  • [33] Incidence and risk factors for hospital-acquired Clostridium difficile infection among inpatients in an orthopaedic tertiary care hospital
    Campbell, K. A.
    Phillips, M. S.
    Stachel, A.
    Bosco, J. A., III
    Mehta, S. A.
    JOURNAL OF HOSPITAL INFECTION, 2013, 83 (02) : 146 - 149
  • [34] Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study
    Schechner, Vered
    Fallach, Noga
    Braun, Tali
    Temkin, Elizabeth
    Carmeli, Yehuda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (08) : 2182 - 2185
  • [35] THE POSTOPERATIVE BURDEN OF HOSPITAL ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION
    Abdelsattar, Z.
    Krapohl, G.
    Alrahmani, L.
    Banerjee, M.
    Krell, R.
    Wong, S.
    Campbell, D., Jr.
    Hendren, S.
    DISEASES OF THE COLON & RECTUM, 2014, 57 (05) : E181 - E182
  • [36] REDUCING HOSPITAL-ACQUIRED CLOSTRIDIUM DIFFICILE RATES ON A BLOOD AND MARROW UNIT
    Rivera, Felicia
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [37] Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
    Barletta, Jeffrey F.
    Sclar, David A.
    CRITICAL CARE, 2014, 18 (06):
  • [38] Inpatient Proton Pump Inhibitor Administration and Hospital-Acquired Clostridium difficile Infection: Evidence and Possible Mechanism
    Wombwell, Eric
    Chittum, Megan E.
    Leeser, Kayla R.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (03): : 244 - 249
  • [39] The Economic Burden of Hospital-Acquired Clostridium difficile Infection: A Population-Based Matched Cohort Study
    Nanwa, Natasha
    Kwong, Jeffrey C.
    Krahn, Murray
    Daneman, Nick
    Lu, Hong
    Austin, Peter C.
    Govindarajan, Anand
    Rosella, Laura C.
    Cadarette, Suzanne M.
    Sander, Beate
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (09): : 1068 - 1078
  • [40] Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
    Jeffrey F Barletta
    David A Sclar
    Critical Care, 18